New injection tested to tame dangerous hormone in dialysis patients
NCT ID NCT06690242
Summary
This study tested whether an experimental injection called MT1013 could safely and effectively lower high parathyroid hormone levels in people with advanced kidney disease who are on regular dialysis. The trial involved 115 participants and compared MT1013 against both an existing treatment and a placebo. The main goal was to see how many people could achieve a significant reduction in their hormone levels.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SECONDARY HYPERPARATHYROIDISM (SHPT) IN SUBJECTS WITH CHRONIC KIDNEY DISEASE (CKD) ON HEMODIALYSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
First Affiliated Hospital College of Medicine, Zhejiang University
Hangzhou, Zhejiang, 310003, China
Conditions
Explore the condition pages connected to this study.